SOLARA Solara Active Pharma Sciences Ltd Capital Structure Changes Announcement 2023 - Equity Offerings Solara Active Pharma Sciences confirms no deviation in use of funds raised through Preferential Issue of Convertible Warrants from the objects stated in the Explanatory Statement to the Notice of Extra-Ordinary General Meeting of the Company dated January 31, 2019 and funds have been fully utilized for the stated purpose during the year 2020 - 2021 itself..Find Corporate Announcements for Press Releases, AGM, Insider Trading & SAST, Results and Corporate Action for Solara Active Pharma Sciences Ltd